Literature DB >> 24644303

Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.

Chun-Yip Hon1, Kay Teschke2, Paul A Demers3, Scott Venners4.   

Abstract

We previously reported that antineoplastic drug contamination is found on various work surfaces situated throughout the hospital medication system (process flow of drug within a facility from initial delivery to waste disposal). The presence of drug residual on surfaces suggests that healthcare workers involved in some capacity with the system may be exposed through dermal contact. The purpose of this paper was to determine the dermal contamination levels of healthcare employees working throughout a hospital and to identify factors that may influence dermal contamination. We selected participants from six hospitals and wiped the front and back of workers' hands. Wipe samples were analyzed for cyclophosphamide (CP), a commonly used antineoplastic drug, using high-performance liquid chromatography-tandem mass spectrometry. Participants were asked about their frequency of handling antineoplastic drugs, known contact with CP on their work shift, gender, job title, and safe drug handling training. In addition, participants were surveyed regarding their glove usage and hand washing practices prior to wipe sample collection. We collected a total of 225 wipe samples. Only 20% (N = 44) were above the limit of detection (LOD) of 0.36ng per wipe. The average concentration was 0.36ng per wipe, the geometric mean < LOD, the geometric standard deviation 1.98, and the range < LOD to 22.8ng per wipe. Hospital employees were classified into eight different job categories and all categories had some dermal contamination levels in excess of the LOD. The job category with the highest proportion of samples greater than the LOD were those workers in the drug administration unit who were not responsible for drug administration (volunteer, oncologist, ward aide, dietician). Of note, the highest recorded concentration was from a worker who had no known contact with CP on their work shift. Our results suggest that a broader range of healthcare workers than previously believed, including those that do not directly handle or administer the drugs (e.g. unit clerks, ward aides, dieticians, and shipper/receivers), are at risk of exposure to antineoplastic drugs. A review of control measures to minimize antineoplastic drug exposure that encompasses a wide array of healthcare workers involved with the hospital medication system is recommended.
© The Author 2014. Published by Oxford University Press on behalf of the British Occupational Hygiene Society.

Entities:  

Keywords:  antineoplastic drugs; cyclophosphamide; dermal contamination; healthcare workers; hospital medication system

Mesh:

Substances:

Year:  2014        PMID: 24644303     DOI: 10.1093/annhyg/meu019

Source DB:  PubMed          Journal:  Ann Occup Hyg        ISSN: 0003-4878


  23 in total

1.  Liquid release as a source of potential drug exposure during the handling of intravenous infusions in nursing.

Authors:  Verena Segner; Renate Kimbel; Philipp Jochems; André Heinemann; Stephan Letzel; Daniel Wollschläger; Bernd Roßbach
Journal:  Int Arch Occup Environ Health       Date:  2017-01-16       Impact factor: 3.015

2.  Causes of Health Care Workers' Exposure to Antineoplastic Drugs: An Exploratory Study.

Authors:  Chun-Yip Hon; Dina Abusitta
Journal:  Can J Hosp Pharm       Date:  2016-06-30

3.  Antineoplastic drug contamination in the urine of Canadian healthcare workers.

Authors:  Chun-Yip Hon; Kay Teschke; Hui Shen; Paul A Demers; Scott Venners
Journal:  Int Arch Occup Environ Health       Date:  2015-01-28       Impact factor: 3.015

Review 4. 

Authors:  Céline Poupeau; Christel Roland; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2016-10-31

5.  Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendations.

Authors:  Thomas H Connor; Matthew D Zock; Amy H Snow
Journal:  J Occup Environ Hyg       Date:  2016-09       Impact factor: 2.155

Review 6.  Meta-analysis of chromosomal aberrations as a biomarker of exposure in healthcare workers occupationally exposed to antineoplastic drugs.

Authors:  Christine Roussel; Kristine L Witt; Peter B Shaw; Thomas H Connor
Journal:  Mutat Res Rev Mutat Res       Date:  2017-08-24       Impact factor: 5.657

7.  Detection and measurement of surface contamination by multiple antineoplastic drugs using multiplex bead assay.

Authors:  Jerome P Smith; Deborah L Sammons; Shirley A Robertson; Jack R Pretty; D Gayle DeBord; Thomas H Connor; John E Snawder
Journal:  J Oncol Pharm Pract       Date:  2014-10-06       Impact factor: 1.809

8.  New approaches to wipe sampling methods for antineoplastic and other hazardous drugs in healthcare settings.

Authors:  Thomas H Connor; Jerome P Smith
Journal:  Pharm Technol Hosp Pharm       Date:  2016-07-27

9.  Environmental Contamination with Cyclophosphamide, Ifosfamide, and Methotrexate: A Study of 51 Canadian Centres.

Authors:  Alexia Janes; Cynthia Tanguay; Nicolas J Caron; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2015 Jul-Aug

10.  Infantile neuroblastoma and maternal occupational exposure to medical agents.

Authors:  Yuhki Koga; Masafumi Sanefuji; Syunichiro Toya; Utako Oba; Kentaro Nakashima; Hiroaki Ono; Shunsuke Yamamoto; Maya Suzuki; Yuri Sonoda; Masanobu Ogawa; Hiroyuki Yamamoto; Koichi Kusuhara; Shouichi Ohga
Journal:  Pediatr Res       Date:  2021-07-09       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.